, N Engl J Med, vol.371, pp.1039-1088, 2014.
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Cancer Res, vol.74, pp.2913-2934, 2014. ,
European cancer mortality predictions for the year 2014, Ann Oncol, vol.25, pp.1650-1656, 2014. ,
Focus on an unusual rise in pancreatic cancer incidence in France, Int J Epidemiol, vol.46, pp.1764-72, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01541663
Risk factors for pancreatic cancer: a summary review of meta-analytical studies, Int J Epidemiol, vol.44, pp.186-98, 2015. ,
Preventable incidence and mortality of carcinoma associated with lifestyle factors among white adults in the United States, JAMA Oncol, vol.2, pp.1154-61, 2016. ,
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies, Br J Cancer, vol.92, pp.2076-83, 2005. ,
Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study, Am J Gastroenterol, vol.107, pp.1730-1739, 2012. ,
Main dietary compounds and pancreatic cancer risk. The quantitative analysis of casecontrol and cohort studies, Cancer Epidemiol, vol.36, pp.60-67, 2012. ,
Interventional endoscopic ultrasound in pancreatic diseases, Pancreatology, vol.6, pp.7-16, 2006. ,
Endoscopic ultrasonography with fine-needle aspiration for histological diagnosis of solid pancreatic masses: a meta-analysis of diagnostic accuracy studies, BMC Gastroenterol, vol.16, p.108, 2016. ,
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial, J Clin Oncol, vol.15, pp.2403-2416, 1997. ,
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N Engl J Med, vol.364, pp.1817-1842, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00598658
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine, N Engl J Med, vol.369, pp.1691-703, 2013. ,
Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis, Endoscopy, vol.41, pp.552-559, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00410404
KRAS G12D mutation subtype is a prognostic factor for advanced pancreatic adenocarcinoma, Clin Transl Gastroenterol, vol.7, p.157, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01301141
Limited predictability of postmortem human brain tissue quality by RNA integrity numbers, J Neurochem, vol.138, pp.53-62, 2016. ,
Impact of RNA degradation on fusion detection by RNA-seq, BMC Genomics, vol.17, p.814, 2016. ,
Salivary MicroRNA in pancreatic Cancer patients, PLoS One, vol.10, p.130996, 2015. ,
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes, Nature, vol.491, pp.399-405, 2012. ,
Whole genomes redefine the mutational landscape of pancreatic cancer, Nature, vol.518, pp.495-501, 2015. ,
Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, vol.531, pp.47-52, 2016. ,
Multiinstitutional tumor banking -lessons learned from a pancreatic cancer biospecimen repository, Pancreas, vol.7, pp.949-54, 2010. ,